Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2447073633;73634;73635 chr2:178572724;178572723;178572722chr2:179437451;179437450;179437449
N2AB2282968710;68711;68712 chr2:178572724;178572723;178572722chr2:179437451;179437450;179437449
N2A2190265929;65930;65931 chr2:178572724;178572723;178572722chr2:179437451;179437450;179437449
N2B1540546438;46439;46440 chr2:178572724;178572723;178572722chr2:179437451;179437450;179437449
Novex-11553046813;46814;46815 chr2:178572724;178572723;178572722chr2:179437451;179437450;179437449
Novex-21559747014;47015;47016 chr2:178572724;178572723;178572722chr2:179437451;179437450;179437449
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: TTA
  • RefSeq wild type template codon: AAT
  • Domain: Ig-132
  • Domain position: 40
  • Structural Position: 69
  • Q(SASA): 0.5404
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/S rs1161493702 -0.393 0.991 N 0.629 0.574 0.804186511895 gnomAD-2.1.1 4.03E-06 None None None None N None 6.46E-05 0 None 0 0 None 0 None 0 0 0
L/S rs1161493702 -0.393 0.991 N 0.629 0.574 0.804186511895 gnomAD-4.0.0 1.59188E-06 None None None None N None 5.66187E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.2055 likely_benign 0.233 benign -1.49 Destabilizing 0.953 D 0.467 neutral None None None None N
L/C 0.5812 likely_pathogenic 0.6377 pathogenic -1.115 Destabilizing 0.999 D 0.581 neutral None None None None N
L/D 0.6778 likely_pathogenic 0.7347 pathogenic -0.677 Destabilizing 0.998 D 0.685 prob.neutral None None None None N
L/E 0.4594 ambiguous 0.4937 ambiguous -0.656 Destabilizing 0.998 D 0.669 neutral None None None None N
L/F 0.1696 likely_benign 0.1827 benign -0.985 Destabilizing 0.982 D 0.563 neutral N 0.515615508 None None N
L/G 0.453 ambiguous 0.5153 ambiguous -1.814 Destabilizing 0.993 D 0.666 neutral None None None None N
L/H 0.3628 ambiguous 0.4037 ambiguous -0.961 Destabilizing 0.999 D 0.699 prob.neutral None None None None N
L/I 0.099 likely_benign 0.0982 benign -0.674 Destabilizing 0.1 N 0.289 neutral N 0.47795841 None None N
L/K 0.4032 ambiguous 0.4324 ambiguous -1.049 Destabilizing 0.993 D 0.631 neutral None None None None N
L/M 0.1126 likely_benign 0.1172 benign -0.717 Destabilizing 0.807 D 0.396 neutral None None None None N
L/N 0.4049 ambiguous 0.4723 ambiguous -0.91 Destabilizing 0.998 D 0.689 prob.neutral None None None None N
L/P 0.1696 likely_benign 0.1918 benign -0.915 Destabilizing 0.998 D 0.685 prob.neutral None None None None N
L/Q 0.2744 likely_benign 0.301 benign -0.999 Destabilizing 0.993 D 0.642 neutral None None None None N
L/R 0.3519 ambiguous 0.3829 ambiguous -0.559 Destabilizing 0.993 D 0.642 neutral None None None None N
L/S 0.2673 likely_benign 0.3032 benign -1.545 Destabilizing 0.991 D 0.629 neutral N 0.440368388 None None N
L/T 0.1656 likely_benign 0.1802 benign -1.389 Destabilizing 0.986 D 0.566 neutral None None None None N
L/V 0.0954 likely_benign 0.0997 benign -0.915 Destabilizing 0.76 D 0.422 neutral N 0.471264511 None None N
L/W 0.3414 ambiguous 0.3616 ambiguous -1.024 Destabilizing 0.999 D 0.685 prob.neutral None None None None N
L/Y 0.4703 ambiguous 0.5113 ambiguous -0.813 Destabilizing 0.998 D 0.588 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.